Due to health issues, this site is no longer maintained and will be shut down shortly.

BMY Bristol Myers Squibb

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.

$68.30  +0.62 (0.91%)
As of 03/27/2023 14:09:03 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/09/2001
Outstanding shares:  2,098,775,978
Average volume:  8,575,789
Market cap:   $140,576,015,006
Current dividend yield:  3.23%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2126335
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy